Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.31 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22206336 | 1.00 | CES2 (0.33) | CES2LMNACES1TDP1L3MBTL1 | |
| SCHEMBL8744118 | 0.89 | CES2 (0.33) | CES2LMNACES1TDP1L3MBTL1 | |
| SCHEMBL28975466 | 0.86 | CES2 (0.34) | CES2LMNACES1TDP1L3MBTL1 | |
| SCHEMBL5492719 | 0.80 | ALDH1A1 (0.34) | CES2LMNACES1HIF1AEPAS1 | |
| SCHEMBL27818420 | 0.76 | CES2 (0.33) | CES2LMNACES1TDP1L3MBTL1 | |
| SCHEMBL27818419 | 0.76 | CES2 (0.33) | CES2LMNACES1TDP1L3MBTL1 | |
| SCHEMBL9064468 | 0.75 | CES2 (0.34) | CES2LMNACES1TDP1L3MBTL1 | |
| SCHEMBL28597160 | 0.75 | CES2 (0.34) | CES2LMNACES1TDP1L3MBTL1 | |
| SCHEMBL28597163 | 0.75 | CES2 (0.34) | CES2LMNACES1TDP1L3MBTL1 | |
| SCHEMBL28734198 | 0.75 | CES2 (0.34) | CES2LMNACES1TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3134537-A1 | METHOD FOR THE SYNTHESIS OF CLOFARABINE | Synbias Pharma AG (CH) | 2017-03-01 | — | — | EP | disclosed |
| WO-2015162175-A1 | METHOD FOR THE SYNTHESIS OF CLOFARABINE | SYNBIAS PHARMA AG (CH) | 2015-10-29 | — | — | WO | disclosed |
| EP-2596005-A2 | ANTIVIRAL AGENTS | Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. (IT) | 2013-05-29 | — | — | EP | disclosed |
| WO-2010084115-A2 | ANTIVIRAL AGENTS | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) | 2010-07-29 | — | — | WO | disclosed |
| EP-1261350-A4 | METHODS FOR SYNTHESIZING 2-CHLORO-9-(2-DEOXY-2-FLUORO-$g(b)-D-ARABINOFURANOSYL)- i 9H /i -PURIN-6-AMINE | SOUTHERN RES INST (US) | 2003-04-16 | — | — | EP | disclosed |
| EP-1261350-A1 | METHODS FOR SYNTHESIZING 2-CHLORO-9-(2-DEOXY-2-FLUORO-$g(b)-D-ARABINOFURANOSYL)- i 9H /i -PURIN-6-AMINE | Southern Research Institute (US) | 2002-12-04 | — | — | EP | disclosed |
| WO-2001060383-A1 | METHODS FOR SYNTHESIZING 2-CHLORO-9-(2-DEOXY-2-FLUORO-β-D-ARABINOFURANOSYL)-9H-PURIN-6-AMINE | SOUTHERN RESEARCH INSTITUTE (US) | 2001-08-23 | — | — | WO | disclosed |
| WO-1999044646-A1 | NOVEL IMAGING AGENTS AND METHODS FOR THE PREPARATION AND USE THEREOF | UNIVERSITY ADVANCED BIO-IMAGING ASSOCIATES (US) | 1999-09-10 | — | — | WO | disclosed |
| EP-0629208-A1 | FLUOROSUGAR DERIVATIVES OF MACROLIDES | PFIZER INC. (US) | 1994-12-21 | — | — | EP | disclosed |
| WO-1993018049-A1 | FLUOROSUGAR DERIVATIVES OF MACROLIDES | PFIZER INC. (US) | 1993-09-16 | — | — | WO | disclosed |
| EP-0145978-A2 | Nucleoside process | Bristol-Myers Company (US) | 1985-06-26 | — | — | EP | disclosed |